David Kim is an IP Litigation associate in the firm’s Orange County office. David’s practice focuses on intellectual property litigation, including patent litigation, trademark litigation, and trade secret litigation. In his patent litigation matters, he has litigated, inter alia, actions involving Abbreviated New Drug Applications under the Hatch-Waxman Act and a Section 337 investigation at the ITC. He has also handled IPR proceedings before the Patent Trial and Appeal Board and opposition and cancellation proceedings before the Trademark Trial and Appeal Board. He has handled matters involving a broad range of subject matter, including pharmaceuticals, medical devices, nucleic acid sequencers, solar cells, and antennas.
Law clerk to the Honorable Dale S. Fischer of the United States District Court for the Central District of California, 2016-2017
Reducing the Delay Between FDA Approval and CMS Reimbursement Coverage - KnobbeMedical.com Blog (May 13, 2016)
FDA Medical Device Safety Tracking System Reform - KnobbeMedical.com Blog (March 22, 2016)
Spectranetics Announces FDA Approval for Turbo-Power™ Laser Atherectomy Catheter Device - KnobbeMedical.com Blog (December 16, 2015)